Are peptides legal in Europe?

This page covers the 27 EU member states plus Iceland, Liechtenstein, Norway and Switzerland. In the EU, the core law is Directive 2001/83/EC, the Community code on medicinal products for human use^[1]. A directive sets common rules that each country writes into its own law, so the details, and the penalties, differ from state to state.

Two layers of regulator sit on top of that law. The European Medicines Agency (EMA) assesses medicines that go through the EU-wide centralised procedure, and the European Commission then grants the authorisation, which is valid in every EU member state and in Iceland, Liechtenstein and Norway^[2]. National competent authorities, such as France's ANSM and Austria's BASG, authorise most other medicines^[2], and each country enforces the rules and sets the penalties^[1]. Switzerland is not covered by EU-wide authorisations^[2]; it has its own regulator, Swissmedic, and its own import rules^[12].

No European regulator keeps a list of "research peptides". The question that matters is whether a product counts as a medicine. For what research peptides are and how the market works, see what are research peptides.

Article 1(2) of the Directive defines a medicinal product in two ways^[1]. The first is presentation: any substance presented as having properties for treating or preventing disease in human beings. The second is function: any substance that may be used in or administered to people to restore, correct or modify physiological functions by a pharmacological, immunological or metabolic action. A product only has to meet one of the two.

Article 2(2) adds a tie-break. Where, taking account of all its characteristics, a product may fall within the definition of a medicinal product and also within another area of EU law, medicines law applies^[1]. So a peptide sold as a "supplement", a "cosmetic" or a "laboratory chemical" can still be treated as a medicine.

Article 6(1) sets the rule that follows. No medicinal product may be placed on the market of a member state unless it has a marketing authorisation, either from that state's competent authority or through the centralised EU procedure^[1]. Most peptides sold online, including BPC-157, TB-500 and retatrutide, have no such authorisation. France's ANSM names retatrutide, TB-500, GHK-Cu and BPC-157 among the peptides being offered without authorisation^[9].

Some peptides are authorised medicines across the EU in specific branded forms. The EMA's summaries say Wegovy (semaglutide), Mounjaro (tirzepatide) and Saxenda (liraglutide) each hold a marketing authorisation valid throughout the EU, and each can only be obtained with a prescription^[4][5][6]. The Directive also says medicines normally prescribed by a doctor to be given by injection are among those that must be prescription-only^[1].

In September 2025 the EMA and the Heads of Medicines Agencies (HMA) warned of a sharp rise in illegal medicines marketed as the GLP-1 receptor agonists semaglutide, liraglutide and tirzepatide^[3]. They said these products are not authorised, may not contain the claimed active substance at all, and may contain harmful levels of other substances^[3]. Their advice is not to buy them without a prescription or from anything other than a legitimate retailer^[3]. See our pages on semaglutide and tirzepatide for the research behind them.

Directive 2011/62/EU, known as the Falsified Medicines Directive, amended the 2001 Directive to stop falsified medicines entering the legal supply chain^[7]. It describes the illegal sale of medicines over the internet as an important threat to public health^[7].

It also added rules on selling medicines online. A seller must be authorised to supply medicines to the public under the law of the country where it is based, the products must comply with the law of the country they are sent to, and the website must display a common EU logo^[1]. The same article allows countries to keep national laws that ban online sales of prescription medicines^[1].

The European Commission says legally operating online pharmacies and retailers in the EU have had to display the logo since 1 July 2015^[8]. It shows the flag of the EU country, or of Norway, Iceland or Liechtenstein, where the seller is registered, and clicking it should take you to that seller's entry on the national register of legal online sellers^[8]. The EMA and HMA say that if a website does not have the logo or is not on a national register, it is operating illegally^[3].

Almost every peptide sold online in Europe carries a "research use only" or "not for human consumption" label. Several national regulators have addressed this directly.

Austria's medicines agency, BASG, said in May 2026 that peptide web shops often use labels such as "for research use only" or "research grade", but that the context of the shops makes clear the products are intended for use in humans^[10]. It said calling a product a research chemical is irrelevant under medicines law, and that many of these peptides are unauthorised medicines whose sale in Austria and import into Austria are prohibited^[10]. It added that buyers, not only sellers and importers, must expect legal consequences, such as being reported^[10].

France's ANSM said in July 2026 that the injectable peptides it found on sale online are fraudulent products that have not been evaluated or authorised, and told the public never to use a product labelled "For research use only" or "Not for human use"^[9]. It has since issued several decisions ordering the withdrawal of products presented as GLP-1 agonists, including one presented as containing retatrutide^[9]. Swissmedic said in June 2026 that labelling a product a "research chemical" or "not for human use" does not change the position if the product is destined for human use^[11].

We have not reviewed statements from every European regulator, and none of this is a court ruling. Still, where regulators have spoken, the message is consistent: the label does not settle the question. Regulators in the UK, US and Australia are covered on their own pages. A research-use label also means no one has taken responsibility for the vial as a medicine; see third-party peptide testing.

The Directive leaves penalties to each country. Article 118a says member states must set penalties that are effective, proportionate and dissuasive, including for making, distributing, importing and selling falsified medicines online^[1]. There is no single EU offence, and no EU-wide rule on whether simply possessing an unauthorised peptide is an offence.

Whether a peptide is also a controlled substance or a banned doping substance is decided nationally too. One example is Germany. Its Anti-Doping Act makes it an offence to acquire or possess a listed substance in a non-small quantity for the purpose of doping in sport, or to bring it into Germany for that purpose^[16]. The list includes growth hormone (somatropin), HCG, CJC-1295, ipamorelin, tesamorelin, sermorelin, GHRP-2, GHRP-6, hexarelin, AOD-9604 and thymosin beta-4 derivatives such as TB-500^[17]. BPC-157 is not on it^[17].

In Norway, the Norwegian Medical Products Agency (DMP) says illegal imports can be reported to the police under the Medicinal Products Act or, for doping agents, under sections 234 and 235 of the Penal Code^[14]. We have not checked the controlled-drug and doping rules of every country covered here. If one country's rules matter to you, check that country's own legislation or take legal advice.

There is no single EU rule on importing medicines for your own use. Each country sets its own, and they differ widely. These are the ones we could confirm from primary sources.

Austria: BASG says importing the unauthorised peptide products it describes into Austria is prohibited^[10]. Norway: DMP says postal consignments containing medicines from abroad are not allowed and may be stopped and destroyed by customs, even if you have a Norwegian prescription^[14]. It names BPC-157 as a substance that will be stopped^[14].

Germany: medicines that need an authorisation may only be brought into Germany if they are authorised there, with exceptions^[15]. One covers medicines obtained from another EU or EEA state in a quantity matching normal personal needs, without commercial intermediation, but only if they may lawfully be marketed in the country they come from^[15]. Another covers mail order from pharmacies in other EU or EEA states that are licensed for mail order^[15]. We found no German authority statement applying these exceptions to research peptides, so we do not say how they would apply.

Switzerland: private individuals may import one month's supply of a medicine for their own use, but not for anyone else, and larger shipments are retained by customs and passed to Swissmedic^[13]. Where the product contains a substance listed as a doping agent, Swissmedic says a zero-tolerance approach normally applies^[12][13], and the recipient pays the administrative costs of an illegal import^[12]. For other countries, check the national regulator before you order.

On 22 June 2026, Swissmedic, the Federal Office for Customs and Border Security and Swiss Sport Integrity ran a targeted check on parcels suspected of containing illegally imported peptides^[11]. Of 46 packages checked, 23 were retained: 21 classed as doping agents and two as medicinal products^[11]. The other 23 had to be released because the quantities were within legal tolerance limits, and recipients were told they would use the products at their own risk^[11].

Swissmedic said about 80% of the checked packages came from Poland, and that products were often wrongly labelled and came from unregulated sources^[11]. It also said anyone in Switzerland who distributes unauthorised medicines, including by dropshipping, is acting illegally and can face criminal proceedings^[11].

Athletes in tested sports anywhere in Europe are covered by the World Anti-Doping Agency's Prohibited List. The 2026 List names BPC-157 under S0, non-approved substances, which are prohibited at all times^[18]. It also names TB-500 and thymosin beta-4, CJC-1295, ipamorelin, the GH-releasing peptides, growth hormone fragments such as AOD-9604, and chorionic gonadotrophin in males^[18].

Swissmedic notes that many peptides sold online are banned in sport, so ordering or using them can also breach anti-doping rules^[11]. A research-use label is no defence to a positive test.

This page summarises primary sources read on the date shown. It is general information, not legal advice. It covers many countries whose laws and enforcement practice differ and change, and we have not reviewed every national rule. Each claim links to its source, so you can check it yourself.

If you buy peptides, PepFinder's job is to help you judge suppliers on evidence: whether they publish independent test results, how reliably they deliver, and what verified buyers say. Compare European peptide suppliers, read how to spot a fake peptide supplier, or see how we rate suppliers. A supplier's listing on PepFinder is not a statement that its products are legal.